menu
    • menu

    Company profile for Averoa

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Averoa is a biopharmaceutical company established in December 2021, dedicated to introducing groundbreaking therapeutic solutions for individuals suffering from renal diseases. Our mission at Averoa is to develop, advance, and bring to market a robust pipeline of products aimed at addressing the substantial unmet medical needs of patients affected by kidney or metabolic disorders. Through our innovative approach, we aspire to ...
    Averoa is a biopharmaceutical company established in December 2021, dedicated to introducing groundbreaking therapeutic solutions for individuals suffering from renal diseases. Our mission at Averoa is to develop, advance, and bring to market a robust pipeline of products aimed at addressing the substantial unmet medical needs of patients affected by kidney or metabolic disorders. Through our innovative approach, we aspire to make a meaningful impact on the lives of those affected by these challenging conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AveroaFrance Flag
    Country
    Country
    France
    Address
    Address
    29 chemin du Vieux Chêne Le Tarmac
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://averoa-pharma.org/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/averoa-pharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AVEROA Receives UK MHRA Approval for Xoanacyl
    AVEROA Receives UK MHRA Approval for Xoanacyl

    05 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-05/averoa-receives-uk-mhra-approval-for-xoanacyl-an-oral-therapy-targeting-key-complications-of-chronic-kidney-disease-ckd

    PHARMIWEB
    05 Nov 2025
    Share Share
    Averoa Gets Eu Approval for Xoanacyl® for Chronic Kidney Disease
    Averoa Gets Eu Approval for Xoanacyl® for Chronic Kidney Disease

    16 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/16/3099643/0/en/AVEROA-receives-European-marketing-authorization-for-XOANACYL-an-Oral-Therapy-for-Chronic-Kidney-Disease-CKD.html

    GLOBENEWSWIRE
    16 Jun 2025
    Share Share
    Averoa Gets Positive Opinion from EMA for Xoanacyl® for CKD
    Averoa Gets Positive Opinion from EMA for Xoanacyl® for CKD

    02 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/02/3054026/0/en/AVEROA-Receives-Positive-Opinion-from-the-European-Medicines-Agency-for-XOANACYL-an-Oral-Therapy-for-Chronic-Kidney-Disease-CKD.html

    GLOBENEWSWIRE
    02 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search